Literature DB >> 24318994

Liver cancer-related gene CYP2E1 expression in HBV transgenic mice with acute liver injury.

Chun Zhang1, Qin Wei, Tao Jiang, Xi Shou, Zhi-Qiang Li, Hao Wen.   

Abstract

The objective of this research was to study the CYP2E1 gene expression in carbon tetrachloride (CCl4)-induced acute liver injury in hepatitis B virus (HBV) transgenic mice. Twenty-four HBV(-) and 24 HBV(+) transgenic mice aged 8 to 10 weeks were selected for the present study. Intraperitoneal injection of 1.0 μL/g of CCl4 (1:4 dissolved in olive oil) to mice was performed to induce acute liver injury model. Eight normal clean-grade C57BL/6 mice were taken as the control group. The control group received saline intraperitoneally. The mice in each group were killed 3, 6, 12, 24, 48, and 72 h after injection. The liver tissue samples of mice were collected. The liver histological changes at different time points in each group were observed under light microscope. The quantitative PCR methods were utilized to measure the relative mRNA levels of CYP2E1 gene in liver tissues. Immunohistochemistry and Western blot techniques were used to observe tissue expression levels of CYP2E1 in each group. Compared with that of the control group, mRNA and protein expression levels of CYP2E1 significantly increased both in the HBV(-) group and in the HBV(+) group after the CCl4 induced the acute liver injury, and it reached the peak at 72h after the CCl4 injection. Compared with the HBV(-) group, the mice in the HBV(+) group had severe liver damage and significantly increased CYP2E1 gene and protein expression levels. In the CCl4-induced acute liver injury of HBV transgenic mice, the CYP2E1 gene expression significantly increased. The results provided evidence for the HBV-induced liver damage and liver cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24318994     DOI: 10.1007/s13277-013-1486-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  [Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma].

Authors:  Xinping Ye; Tao Peng; Tangwei Liu; Zhixiong Su; Kaiyin Xiao; Liming Shang; Ming Su; Lequn Li
Journal:  Wei Sheng Yan Jiu       Date:  2010-01

2.  Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice.

Authors:  Wenzheng Jiang
Journal:  Vaccine       Date:  2011-11-29       Impact factor: 3.641

Review 3.  Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.

Authors:  Grace Lai-Hung Wong; Vincent Wai-Sun Wong
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

4.  Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells.

Authors:  Hui Yang; Yuqiang Nie; Yuyuan Li; Yu-Jui Yvonne Wan
Journal:  Exp Biol Med (Maywood)       Date:  2010-01

Review 5.  CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.

Authors:  Zhong Tian; Yi-Ling Li; Lin Zhao; Chen-Liang Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2012

6.  Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Yonggang Wei; Limei Luo; Xi Chen; Lvnan Yan; Bo Li
Journal:  Tumour Biol       Date:  2012-10-12

7.  Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.

Authors:  Xiaona You; Fabao Liu; Tao Zhang; Yinghui Li; Lihong Ye; Xiaodong Zhang
Journal:  Carcinogenesis       Date:  2013-03-07       Impact factor: 4.944

8.  Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  Alla Arzumanyan; Vaishnavi Sambandam; Marcia M Clayton; Steve S Choi; Guanhua Xie; Anna Mae Diehl; Dae-Yeul Yu; Mark A Feitelson
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

9.  COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.

Authors:  Alfred S L Cheng; Jun Yu; Paul B S Lai; Henry L Y Chan; Joseph J Y Sung
Journal:  Biochem Biophys Res Commun       Date:  2008-07-02       Impact factor: 3.575

10.  Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp.

Authors:  Mohamed M S Farag; Raindy Tedjokusumo; Christa Flechtenmacher; Theresa Asen; Wolfgang Stremmel; Martina Müller; Ulrike Protzer; Kilian Weigand
Journal:  Vaccine       Date:  2012-08-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.